Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Compounds for GI tract motility disorders claimed by Yamanouchi

May 11, 1998

Peptide Therapeutics and Pasteur Merieux-OraVax to develop H. pylori vaccine

May 8, 1998

More European approvals obtained for balsalazide

May 8, 1998

Combination therapy incorporating antioxidants effective for treatment of H. pylori infection

May 8, 1998

YF-476, a potent gastrin/CCK-B antagonist with gastric antisecretory activity

May 7, 1998

Cyclic amines active against H. pylori in development at Takeda

May 7, 1998

FDA advisory committee recommends approval of drug combination for hepatitis C

May 6, 1998

Sagami presents new anti-H. pylori agents

May 6, 1998

YJA-20379, an H+/K+-ATPase inhibitor that inhibits H. pylori

May 1, 1998

Corvas/Schering-Plough HCV protease collaboration extended

May 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2026.
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...